In particular, KRAS activation in pancreatic cancer, also acting as a master regulator, has been reported to promote cancer progression by influencing the properties of several tumor microenvironment components and by recruiting fibroblasts, macrophages, neutrophils, and lymphocytes, among other cells [12]. The gene discussed is KRAS; the disease is pancreatic neoplasm.